RX Imola (RX4900) For Professional Use for the quantitative in vitro determination of various ...

FDA Device Recall #Z-2059-2018 — Class II — May 4, 2018

Recall Summary

Recall Number Z-2059-2018
Classification Class II — Moderate risk
Date Initiated May 4, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Randox Laboratories
Location Kearneysville, WV
Product Type Devices
Quantity 41 analyzers

Product Description

RX Imola (RX4900) For Professional Use for the quantitative in vitro determination of various clinical chemistry tests.

Reason for Recall

Abnormal premature termination of the software could affect the use of the analyser when running patient samples. The impact being a delay in reporting test results.

Distribution Pattern

US Distribution including Puerto Rico and the state of : West Virginia.

Lot / Code Information

GTIN 05055273206104. All serial numbers.

Other Recalls from Randox Laboratories

Recall # Classification Product Date
Z-1286-2023 Class II CRP Immunoturbidimetric reagent. Intended for t... Feb 1, 2023
Z-0969-2018 Class III Immunoassay Premium Controls (3x4x5mL and 12x5m... Aug 11, 2017
Z-0970-2018 Class III Immunoassay Premium Plus Controls (3x4x5mL and ... Aug 11, 2017
Z-2167-2017 Class III Liquid Urine Control Level 3 For Professiona... Apr 27, 2017
Z-0762-2017 Class II The Randox Liquid Cardiac Controls Level 1, Lev... Sep 16, 2016

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.